Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-07-05
2011-07-05
McIntosh, III, Traviss C (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S018700, C536S029200, C536S055000
Reexamination Certificate
active
07973013
ABSTRACT:
Provided are pyrrolo[1,2-f][1,2,4]triazinyl, imidazo[1,5-f][1,2,4]triazinyl, imidazo[1,2-f][1,2,4]triazinyl, and [1,2,4]triazolo[4,3-f][1,2,4]triazinyl nucleosides, nucleoside phosphates and prodrugs thereof, wherein the 2′ position of the nucleoside sugar is substituted with halogen and carbon substitutents. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections caused by both wild type and mutant strains of HCV.
REFERENCES:
patent: 2010/0298257 (2010-11-01), Ross et al.
patent: WO-00/56734 (2000-09-01), None
patent: WO-01/32153 (2001-05-01), None
patent: WO-01/60315 (2001-08-01), None
patent: WO-01/90121 (2001-11-01), None
patent: WO-02/18404 (2002-03-01), None
patent: WO-02/32920 (2002-04-01), None
patent: WO-02/057287 (2002-07-01), None
patent: WO-02/057425 (2002-07-01), None
patent: WO-2004/046331 (2004-06-01), None
patent: WO-2006/065335 (2006-06-01), None
patent: WO2008/005542 (2008-01-01), None
patent: WO-2008/005542 (2008-01-01), None
patent: WO-2008085508 (2008-07-01), None
patent: WO-2008089105 (2008-07-01), None
patent: WO2008/141079 (2008-11-01), None
patent: WO-2008/141079 (2008-11-01), None
patent: WO-2009/132123 (2009-10-01), None
patent: WO-2009/132135 (2009-10-01), None
patent: WO-2010/002877 (2010-01-01), None
Bojack, G et al. (2001) “Design and Synthesis of Inhibitors of Adenosine and AMP Deaminases,”Organic Letters3(6):839-842.
Dudfield, P. et al. (1999) “Synthesis of C-ribosyl imidazo [2,1-f][1,2,4]triazines as inhibitors of adenosine and AMP deaminases,”J. Chem. Soc. Perkin Trans.12929-2936.
Dudfield, P. et al. (1999) “Synthesis of C-ribosyl 1,2,4-triazolo[3,4-f][1,2,4]triazines as inhibitors of adebosine and AMP deaminasses,”J. Chem. Soc. Perkin Trans I2937-2942.
Hayashi, M. (1992) “C-Nucleosides. 17.1A Synthesis of 2-Substituted 7-(β-D-Ribofuranosyl)-Pyrrolo[2,1-f]-1,2,4-Traizines. A New Type of “PURINE LIKE”C-Nucleoside”Heterocycles34(3):569-574.
Knutsen, L. (1984) “Synthesis of Imidazo-fused Bridgehead-nitrogen C—Nucleosides via Dehydrative Coupling Reactions of 2.5-Anhydro-3,4,6-tri-O-benzoyl-D-allonic Acid,”J. Chem. Soc. Perkin Trans Ipp. 229-238.
Knutsen, L. (1985) “Synthesis of Imidazo-fused Bridgehead-nitrogen 2'-Deoxyribo-C-nucleosides: Coupling-Elimination Reactions of 2.5-Anhydro-3,4,6-tri-O-benzoyl-o-allonic Acid,”J. Chem. Soc. Perkin Trans. 1pp. 621-630.
Nishimura, N. (2001) “Synthesis of pyrrolo[2,1-f][1,2,4]triazine C-nucleosides, Isosteres of sangivamycin, tubercidin, and toyocamycin,”Carbohydrate Research331:77-82.
Otter, B. (1996) “Conformational Properties of Purine-Like C-Nucleosides,”Nucleosides&Nucleotides15(1-3):793-807.
Patil, S. (1994) “4-Aza-7,9-Dideazadenosine, A New Cytotoxic Synthetic C-Nucleoside Analogue of Adenosine,”Tetrahedron Letters35(30):5339-5342.
Patil, S. (1994) “Synthesis of Pyrrolo[2, 1-f][1,2,4]triazine Congeners of Nucleic Acid Purines via the N-Amination of 2-Substituted Pyrroles,”J. Heterocyclic Chem.. 31:781-786.
Ramasamy, K. (1986) “Synthesis and Antitumor Activity of Certain 3-βD-Ribofuranosyl-1,2,4-triazolo[3,4-f]-1,2,4-triazines Related to formycin Prepared via Ring Closure of a 1,2,4-Triazine Precursor,”J. Med, Chem.29:2231-2235.
International Search Report for PCT/US2010/049471, mailed Nov. 18, 2010.
Written Opinion for PCT/US2010/049471, mailed Nov. 18, 2010.
Cho Aesop
Kim Choung U.
Metobo Samuel E.
Ray Adrian S.
Xu Jie
Gilead Sciences, Inc.
McIntosh, III Traviss C
LandOfFree
2'-fluoro substituted carba-nucleoside analogs for antiviral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2'-fluoro substituted carba-nucleoside analogs for antiviral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2'-fluoro substituted carba-nucleoside analogs for antiviral... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2633969